In a report released yesterday, Vamil Divan from Guggenheim reiterated a Buy rating on ANI Pharmaceuticals, with a price target of $124.00. The company’s shares closed yesterday at $72.17. Divan ...
Detailed price information for Cogent Biosciences Inc (COGT-Q) from The Globe and Mail including charting and trades.
Zacks Investment Research on MSN
Mirum completes enrollment in late-stage EXPAND study of Livmarli
Mirum Pharmaceuticals MIRM announced that it has completed enrollment in the phase III EXPAND study, which evaluated Livmarli (maralixibat) for treating cholestatic pruritus in patients aged six ...
Janus Henderson Global Life Sciences Fund returned 18.66% and the MSCI World Health Care Index SM returned 10.60%.
Robust financial performance driven by full year 2025 royalty revenue growth of 48% Reiterating 2026 financial guidance of ...
Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals. The company operates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results